TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has provided an announcement.
Giant Biogene Holding Co., Ltd announced an update to its final cash dividend for the year ended December 31, 2024, with a declared dividend of RMB 0.6021 per share. The dividend will be paid in Hong Kong dollars at a rate of HKD 0.6584 per share, with the payment date set for August 29, 2025. This update reflects changes in the default currency and exchange rate, potentially impacting shareholders’ returns and the company’s financial distribution strategy.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$93.70 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd operates in the biotechnology industry, focusing on developing and providing biogene-related products and services. The company is involved in the production and distribution of various biotechnological solutions, catering to a wide range of market needs.
Average Trading Volume: 9,738,363
Technical Sentiment Signal: Buy
Current Market Cap: HK$63.45B
For detailed information about 2367 stock, go to TipRanks’ Stock Analysis page.